Stocklytics Platform
Asset logo for symbol BHVN
Biohaven Pharmaceutical Holding Co Ltd
BHVN52
$39.92arrow_drop_up3.92%$1.53
Asset logo for symbol BHVN
BHVN52

$39.92

arrow_drop_up3.92%

Income Statement (BHVN)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$178.16M-$333.77M-$182.73M-$152.76M-$111.40M
EBITDA-$176.17M-$331.81M-$181.79M-$151.81M-$110.54M
gross Profit--$977.00K-$941.00K-$948.00K-$857.00K
NET Income-$160.30M-$319.77M-$179.50M-$144.75M-$102.57M
total Revenue$0.00$0.00$0.00$0.00$0.00

Balance Sheet (BHVN)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt-$55.40M-$209.40M-$153.97M-$218.84M-$80.13M
stockholders Equity$316.00M$383.74M$301.44M$427.97M$290.00M
total Assets$510.52M$582.64M$418.53M$513.21M$382.73M
total Debt$28.98M$29.74M$30.53M$30.87M$31.56M
total Liabilities$194.51M$198.90M$117.08M$85.23M$92.73M

Cash Flow (BHVN)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$80.37M$321.12M$3.42M$210.05M-$39.65M
free Cash Flow-$141.88M-$170.74M-$103.07M-$115.35M-$96.06M
investing Cash Flow----$58.54M
operating Cash Flow-$141.27M-$167.79M-$102.63M-$114.88M-$94.81M

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Financials

Biohaven Pharmaceutical Holding Co Ltd (BHVN) is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies to improve the lives of patients with neurological and neuropsychiatric diseases. The company's financials reflect its commitment to advancing its pipeline and delivering value to its shareholders. One of the key components of BHVN's financials is its income statement, which provides a summary of the company's revenues, expenses, and net income. The income statement serves as a snapshot of BHVN's financial performance over a specific period of time.
Another important financial metric for BHVN is its EBIT, or earnings before interest and taxes. This measure indicates the company's profitability before taking into account the effects of financing and tax expenses. BHVN's EBITDA, or earnings before interest, taxes, depreciation, and amortization, provides an even clearer picture of the company's operating performance by excluding non-cash charges and other expenses. These metrics help investors and analysts assess BHVN's ability to generate earnings from its core business operations.
BHVN's gross profit, which is the difference between its total revenue and the cost of goods sold, is another key component of its financials. This metric reflects the company's ability to generate revenue from its products and services after accounting for direct production costs. Additionally, BHVN's net income from stockholders measures the portion of profit that is attributable to shareholders after all expenses and taxes have been deducted.
Total revenue is a crucial metric for BHVN, as it represents the sum of all income generated by the company from its various sources, including product sales, royalties, and licensing fees. This metric provides insight into the overall financial health of BHVN and its ability to generate sustainable revenue streams. BHVN's balance sheet, on the other hand, provides a snapshot of the company's financial position at a specific point in time and includes its assets, liabilities, and stockholders' equity.
Cash equivalents, a line item on BHVN's balance sheet, refer to highly liquid assets that can be easily converted into cash. These include short-term investments such as treasury bills and money market funds. BHVN's net debt, which is the difference between its total debt and its cash equivalents, provides insight into the company's ability to meet its financial obligations and manage its debt load effectively. Stockholders' equity, another important line item on BHVN's balance sheet, represents the residual interest in the company's assets after subtracting its liabilities.
Total assets, a key component of BHVN's balance sheet, represent the value of all the resources owned by the company, including cash, accounts receivable, inventory, and property. Total debt, on the other hand, represents the amount of money that BHVN owes to its creditors and other financial institutions. This metric reflects the company's borrowing activities and its ability to handle its debt obligations. Total liabilities, another line item on BHVN's balance sheet, represent the company's obligations to third parties, such as suppliers, employees, and lenders.
BHVN's cash flow statement provides insight into the company's cash inflows and outflows over a specific period of time. This statement is divided into three sections: operating activities, investing activities, and financing activities. Operating cash flow measures the amount of cash generated by BHVN's core business operations, while investing cash flow represents the cash used for investing in new assets or acquiring other companies. Financing cash flow, on the other hand, reflects the cash flows related to BHVN's financing activities, such as issuing or repurchasing stock or repaying debt.
Alongside the cash flow statement, BHVN's free cash flow is an essential metric that helps investors assess the company's ability to generate excess cash after accounting for capital expenditures and other cash outflows. Free cash flow serves as an indicator of BHVN's financial flexibility and its ability to invest in growth opportunities. Finally, investing cash flow represents the cash flows related to BHVN's investing activities, such as purchasing or selling investments or property.
In conclusion, BHVN's financials provide a comprehensive overview of the company's financial performance and position. These metrics, including income statement, EBIT, EBITDA, gross profit, net income, total revenue, balance sheet, cash equivalents, net debt, stockholders' equity, total assets, total debt, total liabilities, cash flow, financing cash flow, free cash flow, investing cash flow, and operating cash flow, help investors and analysts assess BHVN's financial health and evaluate its ability to generate value for shareholders.
add Biohaven Pharmaceutical Holding Co Ltd to watchlist

Keep an eye on Biohaven Pharmaceutical Holding Co Ltd

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level